Loomis, Sayles & Company
NXTM

Loomis, Sayles & Company’s NxStage Medical Inc. NXTM Stock Holding History

Loomis, Sayles & Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-689,146
Closed -$17.3M – 1004
2017
Q2 		$17.3M Sell
689,146
-19,800
-3% -$490K 0.04% 293
2017
Q1 		$19M Buy
708,946
+556,780
+366% +$15.4M 0.05% 260
2016
Q4 		$3.99M Buy
+152,166
New +$3.76M 0.01% 555

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Loomis, Sayles & Company's NXTM Position: Q3 2017 in Review

Loomis, Sayles & Company sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 689,146 shares — an estimated $17.3M sold.

Loomis, Sayles & Company first reported a position in NXTM in Q4 2016 and held it in 3 quarters. The position peaked at $19M in Q1 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Loomis, Sayles & Company reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 689,146 NxStage Medical Inc. shares in Q3 2017, an estimated $17.3M.
  • Loomis, Sayles & Company first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 3 quarters.
  • Loomis, Sayles & Company's NxStage Medical Inc. position peaked at $19M in Q1 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Loomis, Sayles & Company's 13F filing for Q3 2017, filed 14 Nov 2017.